...
首页> 外文期刊>American Journal of Epidemiology >Reproductive Risk Factors for Cutaneous Melanoma in Women: A Case-Control Study
【24h】

Reproductive Risk Factors for Cutaneous Melanoma in Women: A Case-Control Study

机译:女性皮肤黑色素瘤的生殖危险因素:病例对照研究

获取原文
获取原文并翻译 | 示例

摘要

Reproductive hormonal factors may have a potential role in cutaneous melanoma. This study estimated the risk of melanoma in women related to self-reported changes in nevi during pregnancy, while using oral contraceptives and/or hormone replacement therapy. Trained interviewers administered a questionnaire obtaining information about oral contraceptive use, hormone replacement therapy, reproductive history, sun exposure, occupation, and medical history from 318 Caucasian women newly diagnosed between 1991 and 1992 from two pigmented lesion clinics in San Francisco, California, and Philadelphia, Pennsylvania. A total of 395 frequency-matched control participants were recruited from hospital-affiliated outpatient clinics. Clinicians conducted skin examinations to assess the number and type of nevi, extent of freckling, solar damage, and skin type. For women aged less than 55 years, there was an association between a livebirth 5 years before diagnosis (odds ratio = 2.6, 95% confidence interval: 1.3, 5.3) and between number of births and melanoma risk (for ≥3 births: odds ratio = 3.3, 95% confidence interval: 1.7, 6.5; ptrend < 0.001). Changes in nevi during recent pregnancies were a risk factor for melanoma, based upon small numbers (odds ratio = 2.9, 95% confidence interval: 1.1, 8.1). Oral contraceptive use and hormone replacement therapy were not associated with melanoma risk.
机译:生殖激素因子可能在皮肤黑色素瘤中具有潜在作用。这项研究估计了在使用口服避孕药和/或激素替代疗法时,孕妇自我报告的痣改变与黑色素瘤发生风险有关。训练有素的访问者进行了问卷调查,从1991年至1992年在旧金山,加利福尼亚和费城的两个色素沉着性病变诊所新诊断出的318名白人女性中,获得了有关口服避孕药使用,激素替代疗法,生殖史,日照,职业和医疗史的信息。 ,宾夕法尼亚州。从医院附属门诊招募了395名频率匹配的对照参与者。临床医生进行了皮肤检查,以评估痣的数量和类型,雀斑的程度,日光损害和皮肤类型。对于55岁以下的女性,诊断前5年的出生率(几率= 2.6,95%置信区间:1.3、5.3)与出生数量与黑色素瘤风险之间(≥3例出生:优势比)相关。 = 3.3,95%置信区间:1.7,6.5; p 趋势 <0.001)。根据少量的数据,最近怀孕期间痣的变化是黑色素瘤的危险因素(几率= 2.9,95%的置信区间:1.1、8.1)。口服避孕药和激素替代疗法与黑色素瘤风险无关。

著录项

  • 来源
    《American Journal of Epidemiology 》 |2007年第5期| 505-513| 共9页
  • 作者单位

    Statistics and Epidemiology Program Research Triangle Institute International Research Triangle Park NC;

    Department of Epidemiology and Biostatistics University of California San Francisco San Francisco CA;

    Epidemiology and Biostatistics Program Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD;

    Division of Endocrinology and Metabolism Department of Medicine University of California San Francisco San Francisco CA;

    Genetic Epidemiology Branch Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD;

    Pigmented Lesion Study Group School of Medicine University of Pennsylvania Philadelphia PA;

    Dermatology Section Memorial Sloan-Kettering Cancer Center New York NY;

    Melanoma Clinic University of California San Francisco San Francisco CA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号